Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)
Clinical trial NCT04246177 · COMPLETED
Trial details
- NCT number
- NCT04246177
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-22
- Primary completion
- 2025-08-19
- Enrollment
- 479
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.